- Academic Editor
-
-
-
Announcements
Open Access
Editorial
Sodium Glucose Co-Transporter Inhibition, an Expanding Impact
Badr Harfouch1,†, Robert Chilton2,*,†
Show Less
1
Sinai Cardiology Faculty Group, LifeBridge Health, Baltimore, MD 21209, USA
2
Division of Cardiology, Department of Medicine, University of Texas Health Science Centre at San Antonio, San Antonio, TX 78229, USA
*Correspondence: chilton@uthscsa.edu (Robert Chilton)
†These authors contributed equally.
†These authors contributed equally.
Rev. Cardiovasc. Med. 2023, 24(5), 130;
https://doi.org/10.31083/j.rcm2405130
Submitted: 31 March 2023 | Accepted: 7 April 2023 | Published: 26 April 2023
(This article belongs to the Special Issue SGLT2 Inhibition: New Insight in Cardiology)
Copyright: © 2023 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.